PMPN_Pharmaceutical & Medical Packaging News

Pharmaceutical & Medical Packaging News, November/December 2015

Issue link: http://dc.cn.ubm-us.com/i/609216

Contents of this Issue

Navigation

Page 29 of 35

NEW PRODUCTS Packaging Resource Center The Latest in New Products 30 pmpnews.com • Pharmaceutical & Medical Packaging News November/December 2015 Competence Center for Films A manufacturer is announcing that it is increasing manufacturing capacity by 50% for its Schott TopPac prefill- able polymer syringes. After report- ing increased customer demand, the company is installing a new line at the company's center of excellence for prefillable syringes in St. Gallen, Switzerland. "The demand for our polymer syringes has increased since customers appreciate the versatile advantages of the material: It's break resistant and lightweight, yet has a glass-like transparency. And the excellent barrier properties of the Schott TopPac syringe system keep the drug stable over shelf life," states Anil-Kumar Busimi, Head of Global Product Management Syringe Busi- ness, in a news release. The new line will be integrated into Schott's exist- ing set up, the company reports in the release. "Schott TopPac syringes are manufactured in cleanrooms with a fully automated process starting from injection-molding to the final packaging in nest and tub," the com- pany states. "The syringes are steri- lized and are ready for aseptic filling operations." Schott has been manu- facturing glass and polymer syringes in Europe since 1996. Schott recently introduced a polymer syringe designed to improve the safety of sensitive drugs called Schott TopPac SD with a reduced E&L extractables and leachables profile. Schott, www. schott.com. Polymer Syringes A new competence center is handling research and development of polymer films and film laminates for flexible packaging. Located at the company's second-largest production plant in Weiden, Germany, the center rep- resents a multi-million investment for upgrading equipment and infra- structure of the existing local R&D facilities. It has 15 experts working on close to 100 projects every year such as supporting product and sales managers by analyzing and testing the composition of the latest film products; on developing new film formulations with raw material suppliers in order to obtain the optimal quality and meet stringent food contact legislation in a transparent way; and on develop- ing mock-ups of in-house innovations for our customers to meet long-term trends such as more recycling-friendly packaging. The company also provides foil-based products, such as die-cut lid- ding, aluminum container systems, and pharmaceutical blister and coldform packaging. The company has a Com- petence Center for Aluminum and Foil Laminates at its largest plant in Wein- burg, Austria. Constantia Flexibles Group GmbH, www.cflex.com. Sterile Blister Packaging A company is using Perlazid coated film materials for sterile blisters. Accord- ing to the company, sterile blisters are achieved with no need of gamma radiation or treatment with hydrogen peroxide thanks to a self-sterilizing film coating (reduction of up to 6 log levels). It states that it relies on a machine con- cept with a continuous process flow that works without having to sterilize the blister film before or after filling. This is made possible by the principle of a self- sterilizing surface coating with Perlazid developed in 2008 by the Functional Materials Laboratory at ETH Zurich in collaboration with Perlen Converting. The film retains its sterile properties throughout the entire packaging process thanks to its unique coating, accord- ing to Rohrer. The product is efective against resistant bacteria, aiming to fulfill the strictest requirements and renders all other sterilization treatments unnecessary. High throughput rates in the packaging process are guaranteed as the sterile film can be molded, sealed, and punctured without limitation in the same way as conventional films, accord- ing to Rohrer. Perlazid can be applied on flat films, paper, or non-woven, and it can be thermoformed after without decreasing efcacy. Perlazid is a tricalci- umphosphate (TCP) and is treated with silver and copper. TCP is a material that makes up 75% of human bones and can be a natural carrier medium. According to Rohrer, bacteria and fungi recognized TCP as food and open their gates to allow the silver and copper together with the TCP. Rohrer AG, www.rohrerag.com/en/sterile- blister.

Articles in this issue

Links on this page

Archives of this issue

view archives of PMPN_Pharmaceutical & Medical Packaging News - Pharmaceutical & Medical Packaging News, November/December 2015